Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: A pilot study

European Urology

Volumn 46, Issue 1, 2004, Pages 88-94

  Dinis, Paulo ^a   Silva, João ^a   Ribeiro, Maria José ^a   Avelino, António ^b   Reis, Mário ^a   Cruz, Francisco ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

BPH; C fibers; LUTS; Resiniferatoxin

Indexed keywords

RESINIFERATOXIN;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DESENSITIZATION; HUMAN; INFORMED CONSENT; LOWER URINARY TRACT SYMPTOM; MICTURITION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SENSORY NERVE; URGE INCONTINENCE; URINARY FREQUENCY; URINARY TRACT DISEASE; UROFLOWMETRY;

AGED; DITERPENES; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS, UNMYELINATED; NEUROTOXINS; PILOT PROJECTS; PROSTATIC HYPERPLASIA; URINARY BLADDER; URINATION DISORDERS; URODYNAMICS;

EID: 2942525673     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.01.016     Document Type: Article

References (42)

1. Peters T.J., Donovan J.L., Kay H.E., Abrams P., de la Rosette J.J.M.C.H., Porru D., et al. The International Continence Society "Benign Prostatic Hyperplasia" study: the bothersomeness of urinary symptoms. J. Urol. 157:1997;885-889
2. Schulman CC. Tamsulosin. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, editors. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis Medical Media Ltd.; 1996. p. 307-23.
3. McConnell JD. Finasteride therapy for benign prostatic hyperplasia. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, editors. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis Medical Media Ltd.; 1996, p. 259-65.
4. Meigs J.B., Barry M.J., Giovannucci E., Rimm E.B., Stampfer M.F., Kawachi I. Incidence rates and risk factors for acute urinary retention. The health professionals followup study. J. Urol. 162:1999;376-382
5. Yokoyama O, Nagano K, Kawaguchi K, Ueki O, Ohkawa Mitsuo. The influence of prostatic urethral anesthesia in overactive detrusor in patients with benign prostatic hyperplasia. J Urol 1994;151:1554-56.
6. Chai T.C., Gray M.L., Steers W. The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neural plasticity. J. Urol. 160:1998;34-38
7. Geirsson G., Lindstrom S., Fall M. The bladder cooling reflex and the use of cooling as stimulus to the lower urinary tract. J. Urol. 162:1999;1890-1986
8. Steers W.D., de Groat W.C. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J. Urol. 140:1988;864-871
9. Fowler C.J., Jewkes D., McDonald W.I., Lynn B., de Groat W.C. Intravesical capsaicin for neurogenic bladder dysfunction. Lancet. 339:1992;1239
10. Silva C., Rio M.E., Cruz F. Desensitization of bladder sensory fibres by intravesical resiniferatoxin, a capsaicin analogue: long-term results for the treatment of detrusor hyperreflexia. Eur. Urol. 38:2000;444-452
11. Silva C., Ribeiro M.J., Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J. Urol. 168:2002;575-579
12. Kuo H. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J. Urol. 170:2003;835-839
13. Cruz F., Guimarães M., Silva C., Reis M. Supression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet. 350:1997;640-641
14. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51:1999;159-211
15. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Science. 389:1997;816-824
16. Yiangou Y., Facer P., Ford A., Brady C., Wiseman O., Fowler C.J., et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int. 87:2001;774-779
17. Avelino A., Cruz C., Nagy I., Cruz F. Vanilloid receptor type 1 expression in the rat urinary tract. Neuroscience. 109:2002;787-798
18. Birder L.A., Kanai A.J., de Groat W.C., Kiss S., Nealen M.L., Burke N.E., et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc. Natl. Acad. Sci. USA. 98:2001;13396-13401
19. Avelino A., Cruz F., Coimbra A. Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur. J. Pharmacol. 378:1999;17-22
20. Apostolidis A.N., Brady C., Yiangou Y., Harper M., Scaravili F., Fowler C.J., et al. Parallel changes in suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical RTX. Eur. Urol. Suppl. 2(1):2003;91. [Abstract 354]
21. Brown A., Hudson L.J., Nagy I., Winter J., McIntyre P. Rapid capsaicin-induced redistribution of the rat vanilloid receptor subtype 1 in heterologously expressing CHO cells and in DRG neurons. Soc. Neurosci. Abstr. 26:2000;1697. [Abstract]
22. Kedei N., Szabo T., Lile J.D., Treanor J.J., Olah Z., Iadarola M.J., et al. Analysis of the native quaternary structure of vanilloid receptor 1. J. Biol. Chem. 276:2001;28613-28619
23. Winston J., Toma H., Shenoy M., Pasricha P.J. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain. 89:2001;181-186
24. Avelino A., Cruz C., Cruz F. Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application. Brain Res. 951:2002;264-269
25. Dasgupta P., Chandiramani V.A., Beckett A., Scaravilli F., Fowler C.J. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyperreflexia. BJU Int. 85:2000;238-245
26. Birder L.A., Nakamura Y., Kiss S., Nealen M.L., Barrick S., Kanai A.J., et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature Neurosci. 5:2002;856-860
27. Brady C., Apostolidis A.N., Yiangou Y., Baecker P.A., Ford A.P., Fowler C.J., et al. P2X3-immunoreactive nerve fibers in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX). Eur. Urol. Suppl. 2(1):2003;93. [Abstract 362]
28. Guo A., Vulchanova L., Wang J., Li X., Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoreceptor and IB4 binding sites. Eur. J. Neurosci. 11:1999;946-958
29. Vlaskovska M., Kasakov L., Rong W., Bodin P., Bardini M., Cockayne D.A., et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J. Neurosci. 21:2001;5670-5677
30. Cockayne D.A., Hamilton S.G., Zhu Q.M., Dunn P.M., Zhong Y., Novakovic S., et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 407:2000;1011-1015
31. Lazzeri M., Beneforti P., Turini D. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J. Urol. 158:1997;2093-2096
32. Steers W.D., Kolbeck S., Creedon D., Tuttle J.B. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J. Clin. Invest. 88:1991;1709-1715
33. Chuang Y.C., Fraser M.O., Yu Y., Chancellor M.B., de Groat W.C., Yoshimura N. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J. Urol. 165(3):2001;975-979
34. Steers W.D., Creedon D.J., Tuttle J.B. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J. Urol. 155:1996;379-385
35. Andersson P.O., Andersson K.E., Fahrenkrug J., Mattiasson A., Sjogren C., Uvelius B. Contents and effects of substance P and vasoactive intestinal polypeptide in the bladder of rats with and without infravesical outflow obstruction. J. Urol. 140:1988;168-172
36. Steers W.D., Ciambotti J., Etzel B., Erdman S., de Groat W.C. Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. J. Comp. Neurol. 310:1991;401-410
37. Ji R.R., Samad T.A., Jin S.X., Schmoll R., Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 36:2002;57-68
38. Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4, 5)P2-mediated inhibition. Nature. 411:2001;957-962
39. Brading A.F. A myogenic basis for the overactive bladder. Urology. 50(Suppl 6A):1997;57-67
40. Tse V., Wills E., Szonyi G., Khadra M.H. The application of ultrastructural studies in the diagnosis of bladder dysfunction in a clinical setting. J. Urol. 163:2000;535-539
41. O'Reilly B.A., Kosaka A.H., Knight G.F., Chang T.K., Ford A.P., Rymer J.M., et al. P2X receptors and their role in female idiopathic detrusor instability. J. Urol. 167:2002;157-164
42. Fry C.H., Skennerton D., Wood D., Wu C. The cellular basis of contraction in human detrusor smooth muscle from patients with stable and unstable bladders. Urology. 59(Suppl.):2002;3-12